Long-term outcome in liver transplantation candidates with portopulmonary hypertension-Reference-Cited by-同舟云学术

Long-term outcome in liver transplantation candidates with portopulmonary hypertension

Published:2017-03-14 Issue:5 Volume:65 Page:1683-1692
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Savale Laurent¹,Sattler Caroline¹,Coilly Audrey²,Conti Filoména³,Renard Sébastien⁴,Francoz Claire⁵,Bouvaist Hélène⁶,Feray Cyrille⁷,Borentain Patrick⁸,Jaïs Xavier¹,Montani David¹,Parent Florence¹,O'Connell Caroline¹,Hervé Philippe¹,Humbert Marc¹,Simonneau Gérald¹,Samuel Didier²,Calmus Yvon³,Duvoux Christophe⁷,Durand François⁵,Duclos-Vallée Jean Charles²,Sitbon Olivier¹

Affiliation:

1. Université Paris-Sud; Faculté de Médecine, Université Paris-Saclay, and AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin Bicêtre; INSERM UMR_S 999, Hôpital Marie Lannelongue; Le Plessis Robinson France

2. AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, Villejuif, F-94800, France; Inserm, Unité 1193, Université Paris-Saclay, Villejuif, F-94800, France; DHU Hepatinov; Villejuif F-94800 France

3. Service de Transplantation Hépatique; APHP, Hôpital Pitié Salpêtrière; Paris France

4. Département de Cardiologie; Hôpital La Timone, Aix-Marseille Université; Marseille France

5. Service de Transplantation Hépatique; APHP, Hôpital Beaujon; Paris France

6. Département de Cardiologie; CHU; Grenoble France

7. Service de Transplantation Hépatique; APHP, Hôpital Henri Mondor; Paris France

8. Service d'hépatogastroenterologie; Hôpital La Timone, Aix-Marseille Université; Marseille France

Funder

Département Hospitalo-Universitaire Thorax Innovation

Département Hospitalo-Universitaire HEPATINOV

Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique

Publisher

Wiley

Subject

Hepatology

Reference32 articles.

1. Portopulmonary hypertension: survival and prognostic factors;Le Pavec;Am J Respir Crit Care Med.,2008

2. Portopulmonary hypertension: a report from the US-based REVEAL Registry;Krowka;Chest,2012

3. Updated clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2013

4. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie;Eur Respir J,2015

5. Current management approaches to portopulmonary hypertension;Savale;Int J Clin Pract Suppl,2011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of upfront combination therapy for portopulmonary hypertension;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

3. Pulmonary complications of advanced chronic liver diseases: an updated review;Exploration of Digestive Diseases;2024-07-24

4. Portopulmonary hypertension: peculiarities of diagnosis and treatment;EMERGENCY MEDICINE;2024-05-17

5. Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension;European Respiratory Journal;2024-04-25